Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 09, 2022

BUY
$5.1 - $10.0 $321,075 - $629,560
62,956 New
62,956 $434,000
Q2 2021

Aug 11, 2021

SELL
$22.86 - $30.95 $1,165 - $1,578
-51 Closed
0 $0
Q1 2021

May 11, 2021

SELL
$24.58 - $42.82 $58,205 - $101,397
-2,368 Reduced 97.89%
51 $1,000
Q3 2020

Nov 09, 2020

BUY
$32.95 - $50.25 $79,706 - $121,554
2,419 New
2,419 $121,000

Others Institutions Holding FMTX

About Forma Therapeutics Holdings, Inc.


  • Ticker FMTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,860,400
  • Market Cap $958M
  • Description
  • Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatment of sickle cell disease and other hemoglobin...
More about FMTX
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.